Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5196471
Max Phase: Preclinical
Molecular Formula: C25H32OS
Molecular Weight: 380.60
Associated Items:
ID: ALA5196471
Max Phase: Preclinical
Molecular Formula: C25H32OS
Molecular Weight: 380.60
Associated Items:
Canonical SMILES: CC1(C)CCC[C@@]2(C)C1CC[C@@]1(C)Oc3ccc(-c4ccsc4)cc3C[C@@H]12
Standard InChI: InChI=1S/C25H32OS/c1-23(2)10-5-11-24(3)21(23)8-12-25(4)22(24)15-19-14-17(6-7-20(19)26-25)18-9-13-27-16-18/h6-7,9,13-14,16,21-22H,5,8,10-12,15H2,1-4H3/t21?,22-,24+,25-/m1/s1
Standard InChI Key: MPHXWAXDMPKMEY-OCKALLHOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 380.60 | Molecular Weight (Monoisotopic): 380.2174 | AlogP: 7.35 | #Rotatable Bonds: 1 |
Polar Surface Area: 9.23 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 7.18 | CX LogD: 7.18 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.50 | Np Likeness Score: 1.27 |
1. Wang X, Hu N, Kong W, Song B, Li S.. (2022) Facile and divergent optimization of chromazonarol enabled the identification of simplified drimane meroterpenoids as novel pharmaceutical leads., 227 [PMID:34653771] [10.1016/j.ejmech.2021.113912] |
Source(1):